trial

Substance Misuse To Psychosis for Ketamine (SToP-K)

NCTId NCT03485339
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 162 (actual)
Sponsored by The University of Hong Kong
Primary completion 2020-03-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
162 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2018-06-12
Primary completion
2020-03-01
Eligibility
ALL · 12 Years · 65 Years

Interventions & indications

Drugs
genome testing

Sponsors

The University of Hong KongLead Sponsor

Investigators

1
albert KK Chung, MBBS(HK)Principal Investigator

Sites

2 total
Hong Kong, Hong KongHong Kong, Hong Kong

Facts & assertions

4 sourced
Enrollment
162
Phase
NA
Primary Completion Date
2020-03-01
Status
COMPLETED
relationships
The graph out of here
drug
genome testing
drug
lead_sponsor
The University of Hong Kong
company
indication
Psychotic Disorders
indication
Ketamine Abuse
indication
Psychotic Disorders
indication
investigator
albert KK Chung, MBBS(HK)
person